Ignite Creation Date:
2025-12-25 @ 1:46 AM
Ignite Modification Date:
2025-12-26 @ 3:19 AM
Study NCT ID:
NCT05342194
Status:
RECRUITING
Last Update Posted:
2025-04-23
First Post:
2022-04-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Toripalimab Plus Lenvatinib and Gemcitabine-based Chemotherapy in 1L Treatment of Advanced ICC: a Phase III Study
Sponsor:
Shanghai Junshi Bioscience Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-06-19
Start Date Type:
ACTUAL
Primary Completion Date:
2027-05-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-05-31
Completion Date Type:
ESTIMATED
First Submit Date:
2022-04-07
First Submit QC Date:
None
Study First Post Date:
2022-04-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-17
Last Update Post Date:
2025-04-23
Last Update Post Date Type:
ACTUAL